Dr. Adam B Kanis, MD, PHD Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 1 Jarrett White Rd, Tripler Army Medical Center, Attn Mchk-qs, Tamc, HI 96859 Phone: 808-433-2460 Fax: 808-433-1558 |
Dr. Constance P Hastings, M.D. Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 1 Jarrett White Rd, Tripler Army Medical Center, Tamc, HI 96859 Phone: 808-433-6407 |
Dr. Margret E Merino, M.D. Pediatrics Medicare: Medicare Enrolled Practice Location: 1 Jarrett White Rd, Department Of Pediatrics, Tamc, HI 96859 Phone: 808-433-6202 |
Brad Strumwasser, Pediatrics - Developmental – Behavioral Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 1 Jarrett White Rd, Tripler Army Medical Center - Department Of Pediatrics, Tamc, HI 96859 Phone: 808-433-6697 |
Dr. Taylor Lee Sawyer, D.O. Pediatrics - Neonatal-Perinatal Medicine Medicare: Medicare Enrolled Practice Location: 1 Jarrett White Rd, Tripler Army Medical Center Attn: Mchk-qs, Tamc, HI 96859 Phone: 808-433-2460 Fax: 808-433-1558 |
News Archive
The Commonwealth Employment Relations Board (CERB) ruled today that Cambridge Health Alliance (CHA) violated state labor law, by bargaining in bad faith and depriving nurses of their union rights following CHA's decision to prematurely cease negotiations, declare impasse and unilaterally slash nurses' retiree health benefit.
Novel treatments that harness the body's own immune cells to attack cancer cells demonstrate safe and durable responses in patients with relapsed and treatment-resistant blood cancers, according to data presented today at the 56th American Society of Hematology Annual Meeting and Exposition.
Scientists are one step closer to deciphering the molecular signaling process controlling innate immunity with the discovery that a molecule called IRAK1 regulates the expression of the anti-inflammatory cytokine IL-10. Because atherosclerosis patients often have elevated IL-10 levels, IRAK1 may be a viable target for developing therapeutics for atherosclerosis.
CardioPharma is beginning the final funding phase before submitting an NDA for CardiaPill, the world's first patented triple-combination cardiovascular polypill. "The recent news from Kaiser Permanente reinforces that in this cost containment and efficacy oriented healthcare environment, CardiaPill is in the right place at the right time," stated Don Sellers, CardioPharma's Chairman and CEO.
Overall survival of patients with metastatic renal cell carcinoma is extended the more lines of targeted therapy they receive, shows an evaluation of a large retrospective multicentre database.
› Verified 7 days ago